Jump to content

Talk:Bcl-2-associated death promoter

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia

This is the current revision of this page, as edited by Cewbot (talk | contribs) at 18:41, 27 January 2024 (Maintain {{WPBS}} and vital articles: 1 WikiProject template. Create {{WPBS}}. Keep majority rating "Start" in {{WPBS}}. Remove 1 same rating as {{WPBS}} in {{WikiProject Molecular Biology}}.). The present address (URL) is a permanent link to this version.

(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)

comment

[edit]

Your last sentence "After activation, it is able to form a heterodimer with anti-apoptotic proteins and prevent them from stopping apoptosis" needs more nuance & sources (binding to bcl-2 for example). Bad can be stopped if it becomes phosporylated at specific sites (example AKT phosphorylates BAD at s136, this sequesters BAD to cytoplasmic 14-3-3 proteins, keeping it away from anti-apoptotic proteins such as bcl-2). Daviddecraene 11:13, 20 December 2006 (UTC)[reply]

In addition: here is a direct link to a paper on BH3-only proteins: BH3-only proteins — evolutionarily conserved proapoptotic Bcl-2 family members essential for initiating programmed cell death. Daviddecraene 11:21, 20 December 2006 (UTC)[reply]